Secondary Hyperparathyroidism When Initial Parathyroidectomy Has Not Achieved Hormonal Control
This protocol covers the clinical scenario in which secondary hyperparathyroidism persists or recurs after an initial parathyroidectomy, requiring a defined re-operative approach to achieve hormonal and biochemical control.
Prior Treatment: Failure Condition
Initial Parathyroidectomy (PTx) did not meet the operative success criterion: an intact PTH level <60 pg/mL on postoperative day one. Persistent or recurrent secondary hyperparathyroidism following PTx indicates the need for escalation to the next protocol step.
Next-Line Approach (Partial Overview)
The subsequent step involves a re-parathyroidectomy (re-PTx). The operative strategy is determined by the anatomical location of the causative parathyroid tissue — the approach differs depending on whether this tissue is situated in the neck, mediastinum, or a prior autograft site. Full operative details and sequencing are available in the complete protocol.
Clinical goal: a marked reduction in serum calcium following re-PTx, targeting approximately 8.9 mg/dL.
References
DOI: 10.3389/fendo.2023.1169793
- The indication for re-PTx for persistent or recurrent SHPT is the same as that for initial PTx.
- Two kinds of operations are expected: re-PTx in the neck or mediastinum and re-PTx in the autografted forearm.
- Serum calcium levels have been demonstrated to decrease markedly from 10.2 mg/dL to 8.9 mg/dL after re-PTx, although the postoperative serum phosphorus levels were similar to preoperative levels.